BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025

Core Viewpoint - BioStem Technologies Inc. will release its first quarter 2025 financial results on May 12, 2025, and will host a conference call and webcast to discuss the results [1][2]. Company Overview - BioStem Technologies is a MedTech company focused on developing, manufacturing, and commercializing placental-derived biologics for advanced wound care [1][4]. - The company utilizes its proprietary BioREtain processing method to maintain growth factors and preserve tissue structure in its products [4]. - BioStem's quality management system has been accredited by the American Association of Tissue Banks (AATB) and adheres to current Good Tissue Practices (cGTP) and Good Manufacturing Processes (cGMP) [4]. Upcoming Events - The conference call and webcast will feature an overview of the quarter from CEO Jason Matuszewski and CFO Michael Fortunato [2]. - Interested parties can register for the event and follow the company on social media for updates [3]. Contact Information - BioStem Technologies can be contacted via phone at 954-380-8342 or through their website [7]. - Investor relations inquiries can be directed to Adam Holdsworth at adam@holdsworthco.com [7].